Beijing Biostar Pharmaceuticals Co Ltd Sustainability Reports
Beijing Biostar Pharmaceuticals Co., Ltd. is a synthetic biology-driven biopharmaceutical company that develops innovative oncology drugs. Its focus centers on the research and development of microbial metabolite-based treatments like Utidelone.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01QGGQHH4
2 reports from 2024 to 2025